Anzeige
Mehr »
Login
Dienstag, 01.10.2024 Börsentäglich über 12.000 News von 692 internationalen Medien
Aktuelle News: Größter Player im Valley der 1.000%-er!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DV8N | ISIN: GB00BMXNWH07 | Ticker-Symbol: 85V1
Stuttgart
30.09.24
21:31 Uhr
32,200 Euro
-0,150
-0,46 %
Branche
Öl/Gas
Aktienmarkt
Sonstige
1-Jahres-Chart
NOBLE CORPORATION PLC Chart 1 Jahr
5-Tage-Chart
NOBLE CORPORATION PLC 5-Tage-Chart
RealtimeGeldBriefZeit
31,50033,45030.09.
PR Newswire
187 Leser
Artikel bewerten:
(1)

Noble Corporation plc announces changes to its share capital including share repurchases for the month of September 2024

SUGAR LAND, Texas, Sept. 30, 2024 /PRNewswire/ -- Noble Corporation plc ("Noble") (CSE: NOBLE, NYSE: NE) today announces changes to its share capital. During the month of September, Noble has repurchased approximately USD 205.7 million of A ordinary shares under its previously announced share repurchase plan at a weighted average price of approximately USD 35.63 per A ordinary share.

A total of 6,938,128 repurchased A ordinary shares have been cancelled, including certain A ordinary shares repurchased during the month of August.

During the period since September 4, 2024, 45 new A ordinary shares each with a nominal value of USD 0.00001 have been issued.

45 new A ordinary shares have been issued to certain holders of warrants as a consequence of the exercise of warrants. The exercise price was USD 23.13 per A ordinary share for 45 of the new A ordinary shares. The total proceeds to Noble from the warrant exercises amount to USD 1,040.85.

The new A ordinary shares carry the same rights as the existing A ordinary shares of Noble. The new A ordinary shares will be listed on the New York Stock Exchange as well as admitted to trading and official listing on Nasdaq Copenhagen.

As a result of the changes, there are a total of 160,341,619 A ordinary shares of Noble issued and outstanding with a nominal value of USD 0.00001 each.

Pursuant to section 32 of the Danish Capital Markets Act, Noble also hereby announces the total nominal value of its issued share capital and the total number of voting rights:


Number of shares

Number of voting rights

Share capital

A ordinary shares of USD 0.00001

160,341,619

160,341,619

USD 1,603.41619

Total

160,341,619

160,341,619

USD 1,603.41619

Intention to delist from NASDAQ Copenhagen

Noble intends to voluntarily delist from NASDAQ Copenhagen ("NASDAQ"), effective in late 2024 or early 2025. Noble will remain traded on the New York Stock Exchange ("NYSE"), as Noble's primary listing exchange.

To avoid holding Noble shares (in the form share entitlements currently tradeable on NASDAQ, the "Danish Shares") that are not tradeable on a registered market following the effective date of the delisting, holders of Danish Shares currently have the following options:

  • Transfer. Shareholders may transfer their Danish Shares currently trading on NASDAQ to Noble shares trading on NYSE. Shareholders may contact their broker to arrange for transfer. Any transfer, brokerage or holding fees are the responsibility of the shareholder.
  • Sell. Shareholders may sell their Danish Shares on NASDAQ prior to the effective date of the delisting.

Noble has not filed, and has not yet determined when it will file, a formal delisting request with NASDAQ. Additional information, including details regarding the practicalities of final transfers and tax treatment, will be provided after Noble submits its formal delisting request.

More information can be found on the Stockholder Information - FAQ section of the Investor Relations page on our website at www.noblecorp.com.

About Noble Corporation
Noble is a leading offshore drilling contractor for the oil and gas industry. The Company owns and operates one of the most modern, versatile, and technically advanced fleets in the offshore drilling industry. Noble and its predecessors have been engaged in the contract drilling of oil and gas wells since 1921. Noble performs, through its subsidiaries, contract drilling services with a fleet of offshore drilling units focused largely on ultra-deepwater and high specification jackup drilling opportunities in both established and emerging regions worldwide. For further information visit www.noblecorp.com or email investors@noblecorp.com.

IMPORTANT INFORMATION
This announcement is for information purposes only and does not constitute or contain any invitation, solicitation, recommendation, offer or advice to any person to subscribe for or otherwise acquire or dispose of any securities of Noble.

Certain statements in this announcement, including any attachments hereto, may constitute forward-looking statements. Forward-looking statements are statements (other than statements of historical fact) relating to future events and Noble and its subsidiaries (collectively, the "Noble Group") anticipated or planned financial and operational performance. The words "targets", "believes", "continues", "expects", "aims", "intends", "plans", "seeks", "will", "may", "might", "anticipates", "would", "could", "should", "estimates", "projects", "potentially" or similar expressions or the negatives thereof, identify certain of these forward-looking statements. The absence of these words, however, does not mean that the statements are not forward-looking. Other forward-looking statements can be identified in the context in which the statements are made.

Although Noble believes that the expectations reflected in these forward-looking statements are reasonable as of the date of this announcement, such forward-looking statements are based on Noble's current expectations, estimates, forecasts, assumptions and projections about the Noble Group's business and the industry in which the Noble Group operates and/or which has been extracted from publications, reports and other documents prepared by the Noble Group and are not guarantees of future performance or development and involve known and unknown risks, uncertainties and other important factors beyond the Noble Group's control that could cause the Noble Group's actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements.

Any forward-looking statements included in this announcement, including any attachment hereto, speak only as of today. Noble does not intend, and does not assume, any obligations to update any forward-looking statements contained herein, except as may be required by law or the rules of the New York Stock Exchange or Nasdaq Copenhagen. All subsequent written and oral forward-looking statements attributable to Noble or to persons acting on its behalf are expressly qualified in their entirety by the cautionary statements referred to above and contained in this announcement, including any attachment hereto.

Cision View original content:https://www.prnewswire.co.uk/news-releases/noble-corporation-plc-announces-changes-to-its-share-capital-including-share-repurchases-for-the-month-of-september-2024-302263182.html

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.